Javier Ernesto Barreras Gonzalez, MD, PhD, Jorge Gerardo Pereira Fraga, MD, Francisco Llorente Llano, MD, Miguel Angel Martinez Alfonso, MD, PhD, Rafael Torres Peña, MD, PhD, Juan Bautista Olive Gonzalez, MD, Damayanty Hernandez Palacios. National Center for Minimally Invasive Surgery. Havana. Cuba.
Introduction: The treatment of rectal cancer requires highly skilled practice by the entire multidisciplinary team. Important aims of treatment are: to reduce the risk of residual disease in the pelvis, with lower morbidity and to preserve good sphincter function. The TATA procedure is Transanal Transabdominal radical proctosigmoidectomy with coloanal anastomosis. This technique was first developed in 1984 by Dr. Gerald Marks to avoid a permanent colostomy for low-lying rectal cancer. This study reports the long-term results of TATA procedure for low rectal cancer.
Methods and procedures: A prospective study was on 38 patients with low rectal cancer between April 2007 and July 2017 in a tertiary referral university-affiliated center specializing in laparoscopic surgery. All resections were carried out by a team of dedicated colorectal surgery and standard protocol was used for all pre-and-post-operative care. All the patients underwent total mesorectal excision.
Results: 38 consecutive patients (19 male, 19 female, mean age 57) underwent TATA procedure, 30 of them (78,9%) after neoadjuvant radiochemotherapy. The mean operation time was 201 min (range 90-360) and the mean estimated blood loss was 73 ml (range 10-500). The overall incidence of morbidity was 15,8% (6/38) and the mean hospital stay was 4,4 days. The mean follow-up period was 36,8 (range, 1-123) months with a recurrence rate of 7,9% (3/38), overall estimated 5-year survival 78,2% and the disease-free survival rate 89,5%.
Conclusion: Laparoscopic total mesorectal excision with TATA procedure is safe with excellent local recurrence and disease-free survival rate.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 85083
Program Number: P235
Presentation Session: iPoster Session (Non CME)
Presentation Type: Poster